Works matching IS 02724391 AND DT 2016 AND VI 77 AND IP 3
Results: 7
Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson Diseases.
- Published in:
- Drug Development Research, 2016, v. 77, n. 3, p. 109, doi. 10.1002/ddr.21294
- By:
- Publication type:
- Article
Neuroprotective Effects of rhGLP-1 in Diabetic Rats with Cerebral Ischemia/Reperfusion Injury.
- Published in:
- Drug Development Research, 2016, v. 77, n. 3, p. 124, doi. 10.1002/ddr.21297
- By:
- Publication type:
- Article
Antinociceptive Interactions Between Meloxicam and Gabapentin in Neuropathic Pain Depend on the Ratio used in Combination in Rats.
- Published in:
- Drug Development Research, 2016, v. 77, n. 3, p. 134, doi. 10.1002/ddr.21300
- By:
- Publication type:
- Article
Isorhamnetin -3 -O-Glucuronide Suppresses JNK and p38 Activation and Increases Heme-Oxygenase-1 in Lipopolysaccharide-Challenged RAW264.7 Cells.
- Published in:
- Drug Development Research, 2016, v. 77, n. 3, p. 143, doi. 10.1002/ddr.21301
- By:
- Publication type:
- Article
Preparation and Sonodynamic Antitumor Effect of Protohemin-Conjugated Multiwalled Carbon Nanotubes Functionalized with Carboxylic Group.
- Published in:
- Drug Development Research, 2016, v. 77, n. 3, p. 152, doi. 10.1002/ddr.21303
- By:
- Publication type:
- Article
Issue Information-TOC.
- Published in:
- Drug Development Research, 2016, v. 77, n. 3, p. 107, doi. 10.1002/ddr.21308
- Publication type:
- Article
Instruction to Authors.
- Published in:
- Drug Development Research, 2016, v. 77, n. 3, p. 159, doi. 10.1002/ddr.21309
- Publication type:
- Article